Home › Funds › Two Sigma Investments › CRDL
Two Sigma Investments position in CRDL
CARDIOL THERAPEUTICS INC · Health Care
Latest position (Q2 2026)746.94K sh
Reported value held$791.75K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 194.55K | $360.00K | New |
| Q3 2024 | 24.67K | $48.84K | New |
| Q3 2025 | 232.34K | $248.61K | New |
| Q4 2025 | 406.94K | $388.13K | Add |
| Q1 2026 | 534.21K | $721.18K | Add |
| Q2 2026 | 746.94K | $791.75K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CRDL
- Renaissance Technologies 772.84K sh · $819.21K · Q2 2026
- Morgan Stanley 355.03K sh · $376.33K · Q2 2026
- Goldman Sachs Group 333.90K sh · $353.93K · Q2 2026
- JPMorgan Chase & Co 48.08K sh · $49.52K · Q2 2026
- Geode Capital Management 42.20K sh · $44.73K · Q2 2026
- Citadel Advisors 32.80K sh · $34.77K · Q2 2026
- Point72 Asset Management 18.35K sh · $19.45K · Q2 2026
- UBS Group AG 8.47K sh · $8.98K · Q2 2026